- Home
- CCJ
as 11-18-2025 3:48pm EST
Cameco Corp is a provider of uranium needed to generate clean, reliable baseload electricity around the globe. one of those uranium producers. It has three reportable segments, Uranium, Fuel Services, and Westinghouse. It derives maximum revenue from the Westinghouse Segment. It has some projects namely; Millennium, Yeelirrie, Kintyre, and Exploration. The company operates in Canada, Kazakhstan, Germany, Australia, and the United States.
| Founded: | 1987 | Country: | Canada |
| Employees: | N/A | City: | N/A |
| Market Cap: | 45.6B | IPO Year: | N/A |
| Target Price: | $114.38 | AVG Volume (30 days): | 5.9M |
| Analyst Decision: | Buy | Number of Analysts: | 6 |
| Dividend Yield: | Dividend Payout Frequency: | Annual | |
| EPS: | 0.87 | EPS Growth: | 364.36 |
| 52 Week Low/High: | $35.00 - $110.16 | Next Earning Date: | 11-05-2025 |
| Revenue: | $2,487,042,049 | Revenue Growth: | 23.88% |
| Revenue Growth (this year): | 10.98% | Revenue Growth (next year): | 4.31% |
Latest Cameco Corporation News
CCJ Breaking Stock News: Dive into CCJ Ticker-Specific Updates for Smart Investing
Oilprice.com
2 days ago
Nuclear Stocks Crash, With A Potential Payoff Still Years Away
Motley Fool
5 days ago
Better Nuclear Energy Stock: Cameco vs. Oklo
Zacks
6 days ago
Uranium Energy Trades at Premium Value: How to Play the Stock?
MT Newswires
6 days ago
RBC Cuts Cameco's Price Target to C$150 from C$160
Simply Wall St.
6 days ago
ASP Isotopes (ASPI) Is Up 5.2% After Expanding Into Radiopharmaceuticals and Securing Major Supply Agreements—Has the Bull Case Changed?
Simply Wall St.
7 days ago
Should You Reconsider Cameco After Its 943% Five Year Surge and Nuclear Energy Headlines?
Zacks
8 days ago
LEU Stock Falls 11% Post Q3 Earnings Miss: Time to Buy, Hold or Sell?
MarketBeat
9 days ago
Nuclear Stocks Are Melting Down—Should Investors Panic?
Compare CCJ vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CCJ Cameco Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.